These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22969999)

  • 1. Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells.
    Nishikawa S; Ishii H; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Ozaki M; Sakai D; Satoh T; Nagano H; Doki Y; Mori M
    Exp Ther Med; 2012 Jun; 3(6):959-962. PubMed ID: 22969999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic study of dormant gastrointestinal cancer stem cells.
    Nishikawa S; Dewi DL; Ishii H; Konno M; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Noguchi Y; Ozaki M; Sakai D; Satoh T; Doki Y; Mori M
    Int J Oncol; 2012 Sep; 41(3):979-84. PubMed ID: 22735680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD13: Waving the flag for a novel cancer stem cell target.
    Christ B; Stock P; Dollinger MM
    Hepatology; 2011 Apr; 53(4):1388-90. PubMed ID: 21480341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD13 is a therapeutic target in human liver cancer stem cells.
    Haraguchi N; Ishii H; Mimori K; Tanaka F; Ohkuma M; Kim HM; Akita H; Takiuchi D; Hatano H; Nagano H; Barnard GF; Doki Y; Mori M
    J Clin Invest; 2010 Sep; 120(9):3326-39. PubMed ID: 20697159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
    Kim HM; Haraguchi N; Ishii H; Ohkuma M; Okano M; Mimori K; Eguchi H; Yamamoto H; Nagano H; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S539-48. PubMed ID: 21879266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma.
    Sun L; Zhang L; Chen J; Li C; Sun H; Wang J; Xiao H
    Cancer Res Treat; 2020 Apr; 52(2):604-621. PubMed ID: 32019286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress.
    Dai Y; Wang L; Tang J; Cao P; Luo Z; Sun J; Kiflu A; Sai B; Zhang M; Wang F; Li G; Xiang J
    Oncotarget; 2016 May; 7(18):25478-92. PubMed ID: 27009858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of CD13 Enhances the Cytotoxic Effect of Chemotherapeutic Drugs in Hepatocellular Carcinoma Cells.
    Ji S; Ma Y; Xing X; Ge B; Li Y; Xu X; Song J; Xiao M; Gao F; Jiang W; Fang C; Wang X
    Front Pharmacol; 2021; 12():660377. PubMed ID: 34045966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into tumor dormancy: Targeting DNA repair pathways.
    Evans EB; Lin SY
    World J Clin Oncol; 2015 Oct; 6(5):80-8. PubMed ID: 26468441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Recombinational Processes to Induce Dormancy in
    Resende BC; Oliveira ACS; Guañabens ACP; Repolês BM; Santana V; Hiraiwa PM; Pena SDJ; Franco GR; Macedo AM; Tahara EB; Fragoso SP; Andrade LO; Machado CR
    Front Cell Infect Microbiol; 2020; 10():5. PubMed ID: 32117793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents.
    Zhang J; Fang C; Qu M; Wu H; Wang X; Zhang H; Ma H; Zhang Z; Huang Y; Shi L; Liang S; Gao Z; Song W; Wang X
    Front Pharmacol; 2018; 9():1042. PubMed ID: 30258365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage.
    Dou C; Fang C; Zhao Y; Fu X; Zhang Y; Zhu D; Wu H; Liu H; Zhang J; Xu W; Liu Z; Wang H; Li D; Wang X
    Int J Oncol; 2017 Dec; 51(6):1775-1784. PubMed ID: 29039459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenite inhibits the function of CD133
    Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y
    Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
    Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
    Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
    Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y
    BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7.
    Sato Y; Yamada T; Hiroyama T; Sudo K; Hasegawa N; Hyodo I; Nakamura Y
    Cancer Sci; 2019 May; 110(5):1644-1652. PubMed ID: 30784169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of genomic integrity in hematopoietic stem cells.
    Naka K; Hirao A
    Int J Hematol; 2011 Apr; 93(4):434-439. PubMed ID: 21384097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling.
    Skvortsova I; Debbage P; Kumar V; Skvortsov S
    Semin Cancer Biol; 2015 Dec; 35():39-44. PubMed ID: 26392376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations.
    Iliakis G; Murmann T; Soni A
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():166-75. PubMed ID: 26520387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.